Last version:
FLUKA 2023.3.4, April 10th 2024
(last respin 2023.3.4)
flair-2.3-0d 13-Sep-2023

News:

-- Fluka Release
( 10.04.2024 )

FLUKA 2023.3.4 has been released.


font_small font_med font_big print_ascii

 [ 1 ]  [ 2 ]  [ 3 ]  [ 4 ]  [ 5 ]  [ 6 ]  [ 7 ]  [ 8 ]  [ 9 ]  [ back ] 


There are two types of quantities defined for use in radiological protection: protection quantities (defined by the ICRP and used for assessing the exposure limits) and operational quantities (defined by the ICRU and intended to provide a reasonable estimate for the protection quantities).

The following is based on the set of protection quantities recommended in ICRP Publication 60 [3]: it includes the tissue or organ equivalent doses (HT ) and the effective dose (E). The equivalent dose HT in a tissue or organ T is given by:

HT = R (wR · DT, R )
(1)

where DT, R is the average absorbed dose from radiation R, in tissue T, wR is the radiation weighting factor for radiation R and the sum is performed through all kind of radiation that constitue the radiation field considered. Table 1 gives the values of radiation weighting factors as recommended by ICRP. For radiation types and energies that are not included in table 1 an approximation to wR can be obtained by the calculation of the average quality factor, Q, at a depth of 10 mm in the ICRU sphere (for the definition of the ICRU sphere see section 3.2:

Q = 1/D L Q(L) · D(L) · dL
(2)

where D(L)dL is the absorbed dose at 10 mm between linear energy transfer values of L and L + dL and Q(L) is the corresponding quality factor. The relation between Q and L (recommended by ICRP 60) is shown in table 2.

Table 1: Values for radiation weighting factors recommended in ICRP Publication 60 [3].

RADIATION wR
Photons 1
Electrons and muons 1
Neutrons:
E < 10 keV 5
10 keV < E < 100 keV 10
100 keV < E < 2 MeV 20
2 MeV < E < 20 MeV 10
E > 20 MeV 5
Protons, other than recoil protons (E > 2 MeV) 5
α particles, fission fragments, heavy nuclei 20

Table 2: Relation between L in water and the quality factor Q, as recommended by ICRP Publication 60 [3].

L in water
keV / µm
Q(L)
(with L in keV / µm)
< 10 1
10 ÷ 100 0.32 · L – 2.2
> 100 300 / √L

The effective dose E is the sum of the weighted equivalent doses in all the tissues and organs of the body. It is given by the expression:

E = T wT · HT
(3)

where HT is the equivalent dose in tissue or organ T, wT is the weighting factor for tissue T and the sum is performed on all tissue and organs involved in irradiation. Table 3 gives the values of tissue weighting factors as recommended by ICRP.


Table 3: Tissue weighting factors recommended in ICRP Publication 60 [3].

TISSUE or ORGAN wT
Gonads 0.20
Red bone marrow, Colon, Lung, Stomach 0.12
Bladder, Breast, Liver, Oesophagus, Thyroid 0.05
Bone surface, Skin 0.01
Remainder 0.05

The protection quantities HT and E are not directly measurable [4], but may be related by calculation to the radiation field if the condition or irradiation are known. The only way to estimate HT and E is to measure the radiation field outside the body and to convert it to HT and E using previously calculated conversion coefficients.

The mean absorbed dose DT, R is a quantity that cannot be evaluated experimentally, therefore operational quantities [5] (defined in terms of the quality factor Q) should be used. The operational quantities are intended to provide a reasonable estimate of the protection quantities, the goal is that the value of the appropriate protection quantity is less than that of the corresponding operational quantity.

For strongly penetrating radiation the appropriate operational quantity for area monitoring is ambient dose equivalent. The ambient dose equivalent H*(d) at a point in a radiation field is the dose equivalent that would be produced by the corresponding expanded and aligned field in the ICRU sphere at a depth d, on the radius opposing the direction of the aligned field. The recommended value of d for penetrating radiation is 10 mm. The dose equivalent at other depths may be considered when the dose equivalent at 10 mm provides an unacceptable underestimate of the effective dose.


Giuseppe Battistoni; INFN, Milano
Stefan Roesler; CERN, Geneva


Last updated: 10th of October, 2008

© FLUKA Team 2000–2024

Informativa cookies